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TO THE EDITOR
Sjo¨gren–Larsson syndrome (SLS: OMIM
No. 270200) is an autosomal-recessive
hereditary disorder characterized by
congenital ichthyosis, mental retarda-
tion, and spastic diplegia or tetraplegia
(Rizzo, 1993). Rizzo et al. (1988)
revealed that long-chain fatty alcohol
was abnormally accumulated in
cultured fibroblasts, white blood cells
and serum in SLS patients. In 1996, De
Laurenzi et al. (1996) reported that
mutations in the fatty aldehyde dehy-
drogenase (FALDH) gene (ALDH3A2)
underlie SLS. In the present study, we
report novel compound heterozygous
mutations in ALDH3A2 in a Japanese
family with SLS.
A 2-year-old Japanese girl was
suffering from congenital ichthyosis,
mental retardation, spastic tetraplegia,
and recurrent epileptic seizures. The
patient was the first child of non-
consanguineous, healthy Japanese
parents. Ichthyosis was not seen in
any other family members. She was
born as a pre-term baby at 34 weeks 3
days of gestation (body weight, 2392 g),
but not a collodion baby. Physical exami-
nation revealed fine scales and slight
erythema over her whole body (Figure 1).
Hyperkeratosis was also seen on the
palms and soles. Her hair, nails, and
teeth were normal. The skin manifest-
ations were consistent with non-bullous
congenital ichthyosiform erythroderma.
Her extremities were hypertonic. T2-
weighted magnetic resonance imaging
demonstrated a high-intensity area in
her brain periventricular white matter.
Ophthalmologic examination revealed
retinal crystals, generally referred to as
‘‘glistening white dots’’.
To elucidate the precise genetic
abnormality in the family, mutational
analysis was performed in the affected
girl and her parents. Briefly, genomic
DNA isolated from peripheral blood
cells was subjected to PCR amplifica-
tion, followed by direct automated
sequencing using an ABI PRISM 3100
genetic analyzer (ABI Advanced Bio-
technologies, Columbia, MD). Oligo-
nucleotide primers and PCR conditions
used for amplification of all exons and
exon–intron borders of ALDH3A2 were
originally derived from the report by
Rizzo et al. (1999) and were partially
modified for our study (Shibaki et al.,
2004). The entire coding region includ-
ing the intron/exon boundaries for both
forward and reverse DNA strands from
the patient, her parents and 100 healthy
Japanese controls were sequenced. In
the patient, a combination of two novel
heterozygous mutations, 332G4A in
exon 2 and 636T4G in exon 4, were
identified (Figure 2a). The mutation
332G4A was present in her father,
and the mutation 636T4G was demons-
trated in her mother. The presence of
both mutations was excluded in 200
alleles of 100 normal unrelated Japa-
nese individuals. The medical ethical
committee of the Hokkaido University
approved all described studies. These
studies were conducted according to
the Declaration of Helsinki Principles.
The patient’s parents gave their written
informed consent.
The paternal mutation 332G4A in
exon 2 leads to an alteration of the
tryptophan residue at codon 111 into a
stop codon (nonsense mutation
W111X) and this premature translation
termination eliminates approximately
80% of the length of FALDH polypep-
tide (loss of 77.3% length of the FALDH
major splice variant). Thus, this non-
sense mutation is expected to seriously
abolish FALDH function.
The maternal mutation 636T4G in
exon 4 resulted in an alteration of a
serine at codon 212 to arginine
(S212R). FALDH amino-acid sequence
alignment shows that this serine residue
at codon 212 is conserved among
several diverse species (reference se-
quences: CR457422, XP 511337, NP
113919, CAI25890, NP 001016537,
AAK49120) (Figure 2b).
In addition, according to a compar-
ison of 145 full-length aldehyde
dehydrogenase-related sequences by
Perozich et al. (1999), this serine is
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Figure 1. Clinical features of the SLS patient. (a, b) In the perinatal period, xerotic skin, and fine scales
were apparent over the (a) proband’s trunk and (b) hyperkeratosis was severe on her legs. (c, d, e) At
2 years of age, fine, whitish scales were seen on her (c) cheek, (d) thigh, and the (e) dorsal foot.
Abbreviations: FALDH, fatty aldehyde dehydrogenase; SLS, Sjo¨gren–Larsson syndrome
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highly conserved among many of the
ALDH family members, and partici-
pates in one of the 10 most conserved
sequence motifs in ALDHs (Figure 2c).
In addition, analysis of the crystallized
three-dimensional structure of the
related class 3 rat cytosolic ALDH
revealed that this serine is located
adjacent to the first b-strand, b6, of
the six parallels of b-strands, compris-
ing a significant portion of the catalytic
domain of the molecule (Liu et al.,
1997) (Figure 2c). These findings
strongly suggest that the serine at codon
212 is important for connecting the a/b
structure of a dinucleotide-binding
Rossmann fold (Freshney et al., 1994)
to the catalytic domain and/or for
structural folding of the catalytic do-
main, and is therefore essential for the
normal function of the FALDH protein.
The fact that the present patient
harboring the missense mutation
S212R showed typical SLS phenotypic
features strongly suggests that this
serine residue is essential for FALDH
enzymatic function.
FALDH is a microsomal NAD-
dependent enzyme, which is necessary
for the oxidation of long-chain aliphatic
aldehydes into fatty acids (Kelson et al.,
1997). The FALDH gene (ALDH3A2)
located on chromosome 17p11.2 (De
Laurenzi et al., 1996) comprises 11
exons, and is widely expressed in a
variety of tissues (Chang and Yoshida,
1997; Rogers et al., 1997). Until now, a
number of mutations in ALDH3A2 have
been shown to be responsible for SLS
over the world (Rizzo et al., 1999).
Founder effects were observed in cer-
tain areas and races (Rizzo et al., 1999;
Kraus et al., 2000; Rizzo and Carney,
2005). In Japanese patients with SLS,
one homozygous mutation 1157A4G
(N386S) in ALDH3A2 was reported in a
patient of one family (Aoki et al., 2000)
and two other mutations, 481delA and
1087_1089delGTA, were reported in
another family (Shibaki et al., 2004).
We have detected two additional muta-
tions, 332G4A (W111X) and 636T4G
(S212R), in the present family. All the
mutations detected in Japanese families
were distinct one another and we
therefore speculate there is no founder
effect in Japanese cases with ALDH3A2
mutations causing SLS.
The pathogenesis of the ichthyosis
in SLS includes abnormal lamellar or
membranous inclusions in cornified
cells, which were reported in a patient
with SLS, although causative genetic
abnormalities were not known in that
particular case (Ito et al., 1991). The
inclusions were speculated to be lamel-
lar granule-in-origin. Later, a deficiency
in acyl-ceramides in the lipid layer in
the stratum corneum was also reported
in SLS patients (Paige et al., 1994). In a
previous report (Shibaki et al., 2004),
we observed ultrastructurally abnormal
lamellar granules lacking normal lamel-
lar contents in the upper spinous and
granular layers. In addition, we showed
some malformed lamellar granule com-
ponents were secreted into the inter-
cellular space in the stratum corneum
(Shibaki et al., 2004). These observa-
tions suggest defective lamellar granule
formation in SLS. SLS is thought to be a
form of ichthyoses caused by defective
332G>A (W111X) paternal 636T>G (S212R) maternal
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Figure 2. ALDH3A2 mutations in the present SLS patient and sequence alignments around the missense
mutation. (a) Sequence analysis of the ALDH3A2. A combination of heterozygous mutations derived from
their mother (332G4A (W111X) in exon 2) and father (636T4G (S212R) were detected. (b) FALDH
amino-acid sequence alignment shows the level of conservation in diverse species of the amino-acid
S212 (red characters), which was altered by the missense mutation in the present family. (c) A sequence
alignment between the FALDH, rat class 3 and human class 1 and class 2 ALDHs showing the relative
locations of key residues in these enzymes. Serine residue at codon 212 of FALDH is strictly conserved.
Secondary structure components found in the class 3 rat ALDH structure are presented with a bar and
arrows. The bar represents an a-helix and arrows represent b-strands. (Modified from the paper by Liu
et al., (1997).)
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lipid barrier in the stratum corneum
(Akiyama, 2006).
As illustrated here, mutation analysis
of the ALDH3A2 gene is a highly sensi-
tive method to confirm a diagnosis of
SLS, which does not require a skin biopsy
and can complement or replace FALDH
enzymatic assays or analysis in SLS.
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The c-RET proto-oncogene encodes a
receptor-tyrosine kinase and glial cell
line-derived neurotrophic factor ligands,
including glial cell line-derived neuro-
trophic factor, neurturin, artemin, and
persephin, have been reported to be
ligands of RET (Takahashi, 2001). RFP/
RET is a hybrid oncogene between c-
RET and RFP that was isolated by
NIH3T3 transfection assays (Takahashi
et al., 1985). Previously, we established
a metallothionein-I/RFP-RET (RET)-trans-
genic mouse line (242) that sponta-
neously develops systemic skin
melanosis without macroscopic tumors
(Iwamoto et al., 1991; Kato et al., 1999).
Generally, most hair follicles in adult
wild-type mice are in telogen (Kato
et al., 2001). It is basically impossible
to induce continuous anagen hair folli-
cles in adult wild-type mice, although
temporal anagen hair follicles are in-
ducible by shaving hairs (Kato et al.,
2001). Interestingly, adult RET-trans-
genic mice have continuous anagen hair
follicles with hyper melanin production
(Kato et al., 2001, 2004). Moreover, hair
growth of adult transgenic mice was
promoted compared with that of control
C57BL/6 mice (Kato et al., 2001). These
results suggest that a continuous anagen
phase of hair follicles plays an important
role in hair growth.
We also established another RET-
transgenic mouse line (304/B6) (Kato
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